ZyVersa Therapeutics, Inc. (ticker: ZVSA) is an OTC-listed pharma company. DredgeCap's structured extraction of ZVSA's SEC filings surfaces 8 active risk signals, including 3 delisting/deregistration signals, 3 late-filing signals, and 2 auditor-change signals. ZVSA reported no tagged revenue in revenue and -$1.79M for the period ending 2026-03-31, with operating cash flow of -$799K. Cash and equivalents stood at $303K (down 81.2% year-over-year). Total assets of $742K are exceeded by total liabilities of $14.87M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ZVSA Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for ZyVersa Therapeutics, Inc. (ZVSA) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.